Table 1: Study characteristics and patient demographics of included studies.
|
Study # |
Study |
Country |
Design |
N |
Age (years) |
Male (%) |
Hypertension (%) |
Diabetes (%) |
CAD (%) |
CKD (%) |
Bilateral RAS (n, %) |
RAS Definition |
Notes |
|
1 |
Conlon, 2001 [6] |
USA / Ireland |
Prospective cohort |
3987 |
NR |
NR |
High prevalence |
NR |
Present |
Elevated creatinine |
33 (0.8%) |
≥ 75% stenosis |
Angiography cohort |
|
2 |
Uzu, 2002 [7] |
Japan |
Prospective cohort |
44 |
74.8 ± 8.0 |
84 |
100 |
38 |
30 |
100 |
13 (29.5%) |
≥ 75% stenosis |
CKD + atherosclerosis cohort |
|
3 |
Ghaffari, 2009 [8] |
Iran |
Cross-sectional |
732 |
59 ± 9.7 |
43.2 |
100 |
28.4 |
59.3 |
NR |
37 (5.1%) |
≥ 50% (severe ≥ 75%) |
Hypertensive CAD population |
|
4 |
Filiberto, 2023 [9] |
USA |
Retrospective cohort |
161 |
73 |
60 |
100 |
0 |
20 |
60 |
10 (6.2%) |
≥ 50% stenosis |
Vascular surgery cohort |
|
5 |
Liang, 2012 [10] |
China |
Observational |
151 |
Stratified |
NR |
Higher in RAS |
NR |
100 |
Excluded severe CKD |
15 (9.9%) |
≥ 50% (subgroup ≥ 70%) |
CABG candidates |
|
6 |
Schulte-Kemma, 2015 [11] |
Croatia |
Longitudinal |
52 |
NR |
NR |
Present |
NR |
Some |
NR |
NR |
NR |
Renovascular HTN cohort |